The drugmaker plans to add two new production lines to the plant. One is slated to be done by fall, and the other by early 2022. The expansion will make it easier to produce Moderna’s COVID-19 vaccine and booster shots, should they become necessary to increase waning immunity levels or protect against coronavirus variants in coming years.
Moderna is also expanding its manufacturing capacity internationally, seeking to roughly triple its annual global production to about 3 billion vaccine doses in 2022.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
